These COVID-19 clinical trials are active and approved by Health Canada. Many more are pending approval and will be added in the days and weeks ahead.
Help us complete the circle. Add your trial to our list of active COVID-19 Canadian clinical trials and gain access to a wider participant registry.
This study is for healthy adults who do not have COVID-19. The study participants will receive Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5) (Ad5-nCoV). The study has two phases, Phase 1 is to see if the vaccine is safe to use in humans, and Phase 2 is to find an effective dose and timing for the vaccine.
This study is for people who are hospitalized for COVID-19. All study participants will get convalescent plasma (a part of blood) to see if it prevents death and reduces intubation, and to see whether people are able to leave the intensive care unit and the hospital faster.
This study is for children hospitalized with COVID-19. Study participants will know which therapy they receive, and it will be either (1) standard of care, or (2) convalescent plasma and standard of care. The study is to see if convalescent plasma improves clinical symptoms of COVID-19 and to see if it prevents death.
This study is for people who are hospitalized for COVID-19. The study compares 4 different treatments to see if they will improve clinical symptoms, and to see if it will improve symptoms faster. The study participants will know which treatment they are getting, which will be one of: (1) Lopinavir/ritonavir, (2) Hydroxychloroquine sulfate, (3) Baricitinib, or (4) standard care.